TNFRSF1A and metabolic dysfunction-associated steatohepatitis: Indeed, other authors described a reduction of hepatocellular injury, as well as liver steatosis and fibrosis, in a diet-induced NASH murine model after an 8-week treatment with an anti-TNFR1 antibody [24].